For more than 20 years, CIRT has been collecting what is now the world’s largest registry of information from patients who have undergone cardiac imaging studies. The information derived from historical, demographical, clinical, imaging and outcomes data from patients undergoing cardiac imaging procedures—including nuclear cardiology single-photon emission computed tomography and positron emission tomography, cardiac CT and cardiac MRI at Cedars-Sinai—will be used to conduct retrospective and future analyses to help advance the field of cardiac imaging focused around the following general aims to investigate:
- Technical questions such as issues related to the acquisition parameters, image processing and quantitative analysis
- Diagnostic capabilities to detect disease and assess risk compared to other assessments
- Prognostic value to predict adverse outcomes of cardiovascular disease and all cause mortality
- The usefulness of the testing to guide clinical decision making and monitor therapy with the goal of preventing adverse outcomes
Using this registry, CIRT has performed analyses that have shaped the way physicians around the world use nuclear cardiology testing to guide patient management including properly selecting patients for angioplasty or bypass surgery and reducing unnecessary invasive procedures.